使用电子式触发器确定胰岛素诱导低血糖的原因
Kamil Evy A Bantol1, Yingchao Zhong1, Joanne Bruno2
1Department of Medicine, NYU Langone Health, New York, NY.
概括
低血糖,低血糖是常见的住院患者伤害. 这项研究确定了胰岛素剂量错误和无法停止胰岛素的关键原因,需要多方面的预防解决方案.
科学领域:
- 内部医学 内部医学
- 临床药房 临床药房
- 患者安全 患者安全
背景情况:
- 低血糖 (血糖<70 mg/dL) 是住院患者常见的与药物相关的伤害.
- 鉴定和分析低血糖的原因对于改善患者安全至关重要.
研究的目的:
- 开发和验证用于识别住院患者低血糖事件的电子触发器.
- 为了分析胰岛素介导的低血糖症的根本原因.
主要方法:
- 一个电子触发器被开发和通过一个多步骤的过程验证.
- 在2023年1月1日至12月31日期间,确定了111起低血糖事件.
- 对确定的低血糖事件进行了定性分析.
主要成果:
- 低血糖的最常见原因与胰岛素订单有关,包括过高的初始/调整剂量和未能停止胰岛素.
- 饮食状况的变化和高血症治疗也成为了促成因素.
- 确定了多种致病原因,突出显示了低血糖预防的复杂性.
结论:
- 在住院患者中预防低血糖症需要多方面的策略.
- 建议对处方胰岛素的医疗保健提供者进行教育干预.
- 解决胰岛素剂量和中止方案对于减少低血糖事件至关重要.
相关概念视频
Hypoglycemia and Glucagon
796
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
796
Insulin: Dosing Regimen and Adverse Effects
670
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
670
Hormones Regulating Blood Glucose
6.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K
Oral Hypoglycemic Agents: Glinides
585
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
585
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.1K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K


